{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"Choosing the Right Path: JAK Inhibitors or Biologics for Atopic Dermatitis?","description":"This is the fifth episode of our new &quot;Program on JAK Inhibitors for Atopic Dermatitis&quot; series, hosted by expert dermatologist Dr. Christopher Bunick, MD, PhD. This episode, &quot;Choosing the Right Path: JAK Inhibitors or Biologics for Atopic Dermatitis?&quot;, featuring expert dermatologist Dr. Naiem Issa, MD, PhD, discusses the following topics:   Mechanistic differences between JAKi and biologics for treatment of AD   Clinical data supporting the safety of JAKi in head-to-head trials compared to biologics   Pearls for prescribing JAKi to AD patients   Strategies for choosing JAKi vs biologics based on safety and patient factors   ","author_name":"DermDocs","author_url":"http:\/\/dermdocs.libsyn.com\/website","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/32811917\/height\/90\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/88AA3C\/\" height=\"90\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/content\/177119067"}